Home
Section for epidemiology and medical statistics
DRONE

DRONE - Drug Repurposing fOr Neurological disEases

The project aims to develop new and effective treatments for the neurological diseases Parkinson's disease (PD), multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD).

DRONE logo
Photo:
https://www.facebook.com/z.rmnwsk

Main content

The researchers will analyze data from the Norwegian health registries, including the Prescription Register and Patient Register, using an innovative drug repurposing approach based on the history of prescriptions for the entire Norwegian population during last 16 years. The newly developed methodology will help identify drug candidates for new treatment for the diseases. These candidates will be then validated in experimental studies (both in vitro and in vivo) in collaboration with the excellent researchers at Harvard University in Boston, USA

Apart from securing its own funding via Michael J. Fox foundation and NRC (The Research Council of Norway), DRONE is also part of the initiative on the treatment of neurological disease, NeuroSysMed (Norway's first research center for clinical treatment in neurology) at Haukeland University Hospital / UiB.